Suriname to Introduce PCV Vaccine to Protect Children from Pneumococcal Infections
Suriname is preparing for the introduction of the pneumococcal conjugate vaccine (PCV) into its national immunization program, according to the Ministry of Health, Welfare and Labour. The initiative is designed to protect young children against severe and potentially life-threatening pneumococcal infections, including pneumonia and meningitis.
- Suriname’s Ministry of Health is collaborating with international agencies including Gavi, PAHO, WHO, and UNICEF to integrate the PCV vaccine into the national immunization schedule.
- Gavi will fund 50 percent of the introduction costs, with support facilitated through the World Bank’s IBN scheme.
- The project scope includes strengthening the national health system, improving cold chain facilities, and enhancing logistical infrastructure to reach remote interior regions.
International Collaboration and Funding Structure
To implement the vaccine rollout, the Ministry of Health, Welfare and Labour is working alongside the international vaccine alliance Gavi, the Pan American Health Organization (PAHO), the World Health Organization (WHO), and UNICEF. During recent consultations between the ministry and a delegation representing Gavi and UN partners, concrete steps were established for incorporating the vaccine.
Under the financial agreement, Gavi will cover 50 percent of the total introduction costs. This support is facilitated through the International Business Network (IBN) scheme of the World Bank. A technical team is currently developing the definitive project proposal, which is scheduled for submission to Gavi’s independent review committee in Geneva by the end of October.
Strengthening Healthcare Infrastructure and Cold Chain Logistics
The collaborative framework extends beyond vaccine procurement. According to the ministry, the initiative targets foundational improvements to the broader healthcare system in Suriname. Planned upgrades focus on the cold chain—including refrigeration facilities—and logistical infrastructure. These enhancements aim to secure the uninterrupted supply and availability of essential vaccines down to remote interior communities.
To maintain long-term program continuity, the ministry will engage in discussions with the Ministry of Finance in the coming weeks. These talks will finalize financial scheduling and establish the required domestic co-financing.
Minister André Misiekaba of Health, Welfare and Labour emphasized the critical value of sustained investments in public health infrastructure during the stakeholder meetings. According to the minister, funding routine immunization programs yields measurable health dividends and reduces long-term expenditures associated with acute medical interventions.
By introducing the PCV vaccine, public health authorities in Suriname aim to systematically strengthen the protection of children against severe pneumococcal infections.